CBD Market in the US Expected to Reach $20.4 Billion by 2023

Mar.04.2023
CBD Market in the US Expected to Reach $20.4 Billion by 2023
This article is about the growth of the CBD industry in the US market and its potential global impact.

Statement:


This article is limited to conducting research on the related industries and overseas markets, and does not make recommendations for any products or provide comments on any domestic policies.


The legality of the products mentioned in the article is only limited to overseas areas. Domestic readers are advised to take note and strictly comply with relevant laws and regulations of China.


This article does not constitute any investment or consumer advice.


This article is not suitable for minors to read.


On the morning of March 3rd, Eastern Time, two employees from the Washington News Center of 2FIRSTS interviewed Caesar, their marketing manager, at the APE exhibition. Caesar stated that the CBD market in the United States is expected to reach $20.4 billion by 2023.


During an interview with 2FIRSTS, Caesar revealed that APE has noticed a significant increase in sales of CBD products at recent exhibitions. He noted that compared to the tobacco industry and other related industries, the growth in CBD sales is much more substantial. It is projected that the CBD market in the United States will reach $20.4 billion by the year 2023, as stated by Caesar.


Caesar stated that the use of CBD is becoming increasingly widespread. Currently, many companies have started to incorporate CBD in food and drink products, such as butter, oil, or other grains.


Caesar announced that their next exhibition will be held in Medellin, South America. Over 90% of the exhibition spaces have already been sold. The exhibition in Dallas, USA, sold out 70% of its spaces within five months after the show.


Furthermore, Caesar told 2FIRSTS that APE was formerly known as the USA CBD Expo, but due to the growth of e-cigarettes, the USA CBD Expo had to add e-cigarette categories, thus evolving into the Alternative Products Expo.


Further reading:


The media company 2FIRSTS has been named the official partner of the APE Expo, a tobacco trade show in the United States. As a result, they will provide comprehensive coverage of the event.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Hungary’s Continental Tobacco Launches New Slay Nicotine Pouch Brand in UK Targeting Female Consumers
Hungary’s Continental Tobacco Launches New Slay Nicotine Pouch Brand in UK Targeting Female Consumers
Hungary’s Continental Tobacco Group has launched its Slay nicotine pouch brand in the UK, featuring compact, pastel-toned packaging and backed by a multi-million-pound investment and retail pilot programme to build its presence in the local market.
Dec.03 by 2FIRSTS.ai
BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
British American Tobacco’s (BAT) Vuse Ultra vaping product has been listed among winners on the U.S. GOOD DESIGN Awards website, in the “Personal Experience” category, according to the project page. The page identifies the award year as 2025 and names BAT (London) as both the entrant and the manufacturer.
Jan.20 by 2FIRSTS.ai
South Korea’s National Assembly Passes Law Classifying E-Cigarettes as Tobacco Products with Full Equivalent Regulation
South Korea’s National Assembly Passes Law Classifying E-Cigarettes as Tobacco Products with Full Equivalent Regulation
South Korea’s National Assembly recently passed a comprehensive package of 79 bills that, among other measures, formally classifies liquid vapes — e-cigarette products using nicotine-containing e-liquids — as tobacco products. These products will now be subject to the same taxation, sales restrictions and advertising controls as traditional cigarettes, and the vaping industry in South Korea is expected to face significant adjustments in compliance costs, market access and business strategy.
Dec.03
Imperial Brands names John Rishton chair-designate, to take over as chair in December 2026
Imperial Brands names John Rishton chair-designate, to take over as chair in December 2026
Imperial Brands said in a statement on its website that John Rishton will join the board in July 2026 and assume the role of chair in December, succeeding current chair Thérèse Esperdy, who will retire at that time.
Jan.21 by 2FIRSTS.ai
NZ Government Eyes Sale of Smokeless Tobacco; Critics Warn of “Backslide”
NZ Government Eyes Sale of Smokeless Tobacco; Critics Warn of “Backslide”
Associate Health Minister Casey Costello faced renewed scrutiny in Parliament’s health select committee over her handling of tobacco-related policy and alleged ties to the tobacco industry. The government is considering allowing smokeless nicotine products such as snus and nicotine pouches, provided they meet safety and youth-access regulations.
Dec.05 by 2FIRSTS.ai
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International (PMI) said its U.S.-related investments have topped $20 billion since 2022, when it entered the U.S. market through its roughly $19 billion acquisition of Swedish Match. The company also said it plans to launch its heated tobacco product IQOS ILUMA in the United States pending authorization from the U.S. Food and Drug Administration (FDA).
Jan.16 by 2FIRSTS.ai